187 related articles for article (PubMed ID: 7479692)
1. Engineering disulfide-linked single-chain Fv dimers [(sFv')2] with improved solution and targeting properties: anti-digoxin 26-10 (sFv')2 and anti-c-erbB-2 741F8 (sFv')2 made by protein folding and bonded through C-terminal cysteinyl peptides.
McCartney JE; Tai MS; Hudziak RM; Adams GP; Weiner LM; Jin D; Stafford WF; Liu S; Bookman MA; Laminet AA
Protein Eng; 1995 Mar; 8(3):301-14. PubMed ID: 7479692
[TBL] [Abstract][Full Text] [Related]
2. Avidity-mediated enhancement of in vivo tumor targeting by single-chain Fv dimers.
Adams GP; Tai MS; McCartney JE; Marks JD; Stafford WF; Houston LL; Huston JS; Weiner LM
Clin Cancer Res; 2006 Mar; 12(5):1599-605. PubMed ID: 16533787
[TBL] [Abstract][Full Text] [Related]
3. Targeting c-erbB-2 expressing tumors using single-chain Fv monomers and dimers.
Tai MS; McCartney JE; Adams GP; Jin D; Hudziak RM; Oppermann H; Laminet AA; Bookman MA; Wolf EJ; Liu S
Cancer Res; 1995 Dec; 55(23 Suppl):5983s-5989s. PubMed ID: 7493381
[TBL] [Abstract][Full Text] [Related]
4. Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv.
Adams GP; McCartney JE; Tai MS; Oppermann H; Huston JS; Stafford WF; Bookman MA; Fand I; Houston LL; Weiner LM
Cancer Res; 1993 Sep; 53(17):4026-34. PubMed ID: 7689421
[TBL] [Abstract][Full Text] [Related]
5. Tumor targeting in a murine tumor xenograft model with the (sFv')2 divalent form of anti-c-erbB-2 single-chain Fv.
Huston JS; Adams GP; McCartney JE; Tai MS; Hudziak RM; Oppermann H; Stafford WF; Liu S; Fand I; Apell G
Cell Biophys; 1994; 24-25():267-78. PubMed ID: 7736532
[TBL] [Abstract][Full Text] [Related]
6. Optimization of in vivo tumor targeting in SCID mice with divalent forms of 741F8 anti-c-erbB-2 single-chain Fv: effects of dose escalation and repeated i.v. administration.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Tai MS; Huston JS; Stafford WF; Bookman MA; Houston LL; Weiner LM
Cancer Immunol Immunother; 1995 May; 40(5):299-306. PubMed ID: 7600561
[TBL] [Abstract][Full Text] [Related]
7. Radiometal labeling of recombinant proteins by a genetically engineered minimal chelation site: technetium-99m coordination by single-chain Fv antibody fusion proteins through a C-terminal cysteinyl peptide.
George AJ; Jamar F; Tai MS; Heelan BT; Adams GP; McCartney JE; Houston LL; Weiner LM; Oppermann H; Peters AM
Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8358-62. PubMed ID: 7667295
[TBL] [Abstract][Full Text] [Related]
8. Enhanced tumor specificity of 741F8-1 (sFv')2, an anti-c-erbB-2 single-chain Fv dimer, mediated by stable radioiodine conjugation.
Adams GP; McCartney JE; Wolf EJ; Eisenberg J; Huston JS; Bookman MA; Moldofsky P; Stafford WF; Houston LL; Weiner LM
J Nucl Med; 1995 Dec; 36(12):2276-81. PubMed ID: 8523119
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.
Schier R; Marks JD; Wolf EJ; Apell G; Wong C; McCartney JE; Bookman MA; Huston JS; Houston LL; Weiner LM
Immunotechnology; 1995 May; 1(1):73-81. PubMed ID: 9373335
[TBL] [Abstract][Full Text] [Related]
10. Medical applications of single-chain antibodies.
Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
[TBL] [Abstract][Full Text] [Related]
11. Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies.
Strube RW; Chen SY
J Immunol Methods; 2002 May; 263(1-2):149-67. PubMed ID: 12009211
[TBL] [Abstract][Full Text] [Related]
12. Mammalian cell expression of single-chain Fv (sFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains.
Dorai H; McCartney JE; Hudziak RM; Tai MS; Laminet AA; Houston LL; Huston JS; Oppermann H
Biotechnology (N Y); 1994 Sep; 12(9):890-7. PubMed ID: 7765352
[TBL] [Abstract][Full Text] [Related]
13. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
Huston JS; Levinson D; Mudgett-Hunter M; Tai MS; Novotný J; Margolies MN; Ridge RJ; Bruccoleri RE; Haber E; Crea R
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5879-83. PubMed ID: 3045807
[TBL] [Abstract][Full Text] [Related]
14. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
[TBL] [Abstract][Full Text] [Related]
15. Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv.
Whitlow M; Filpula D; Rollence ML; Feng SL; Wood JF
Protein Eng; 1994 Aug; 7(8):1017-26. PubMed ID: 7809028
[TBL] [Abstract][Full Text] [Related]
16. Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells.
Li J; Wang Y; Wang Z; Dong Z
Immunol Lett; 2000 Mar; 71(3):157-65. PubMed ID: 10722867
[TBL] [Abstract][Full Text] [Related]
17. A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv.
Tai MS; Mudgett-Hunter M; Levinson D; Wu GM; Haber E; Oppermann H; Huston JS
Biochemistry; 1990 Sep; 29(35):8024-30. PubMed ID: 2261460
[TBL] [Abstract][Full Text] [Related]
18. Correct disulfide pairing and efficient refolding of detergent-solubilized single-chain Fv proteins from bacterial inclusion bodies.
Kurucz I; Titus JA; Jost CR; Segal DM
Mol Immunol; 1995 Dec; 32(17-18):1443-52. PubMed ID: 8643113
[TBL] [Abstract][Full Text] [Related]
19. Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology.
Turner DJ; Ritter MA; George AJ
J Immunol Methods; 1997 Jun; 205(1):43-54. PubMed ID: 9236914
[TBL] [Abstract][Full Text] [Related]
20. Characterization of anti-mouse Fc gamma RII single-chain Fv fragments derived from human phage display libraries.
McCall AM; Amoroso AR; Sautès C; Marks JD; Weiner LM
Immunotechnology; 1998 Jun; 4(1):71-87. PubMed ID: 9661816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
